Valeant Pharmaceuticals International (VRX) 93.77 $VRX
3 Popular Stocks That Have Us Spooked
Brian Feroldi, Sean Williams, and Jason Hall, The Motley Fool - Motley Fool - Sat Oct 31, 12:17PM CDT
Photo by Brian Feroldi We Fools strongly believe that buying and holding high-quality stocks is one of the best ways to build wealth over time. Great companies can provide their investors with market-smashing returns, and turn small amounts of...
BOFI: 80.01 (-13.04), VRX: 93.77 (-17.73), MNKD: 3.31 (-0.15)
'Fast Money' Recap: October Was Great but What About November?
at The Street - Sat Oct 31, 4:00AM CDT
The trading panel discussed whether the market can rally and which stock to buy ahead of earnings.
TSLA: 206.93 (-4.70), VRX: 93.77 (-17.73), SPY: 207.93 (-0.90), SHAK: 45.57 (+1.25), DIS: 113.74 (-1.30), TM: 122.62 (-0.62), KORS: 38.64 (-0.05), KATE: 17.97 (-0.22), WEN: 9.16 (+0.09), CBS: 46.52 (-0.10)
Roll-Ups and Yahoo! Look Risky; Trust Sam Zell; A Bit of Bafflement: Best of Kass
at The Street - Fri Oct 30, 8:00PM CDT
In highlights from this week's trading diary and posts, Kass talks about roll-up problems, why he sold Yahoo!, what one proven prognosticator is selling, and why he's just plain confused.
AMZN: 625.90 (-0.65), YHOO: 35.62 (+0.57), VRX: 93.77 (-17.73), IBM: 140.08 (-0.47), SUNE: 7.30 (-1.03), GOOGL: 737.39 (-7.46), MSFT: 52.64 (-0.72), BABA: 83.83 (+1.61)
Wolf Haldenstein Adler Freeman & Herz LLP Commences a Class Action Lawsuit Against Valeant Pharmaceuticals International, Inc. in the United States District Court for the District of New Jersey -- VRX
GlobeNewswire - Fri Oct 30, 4:30PM CDT
Wolf Haldenstein Adler Freeman & Herz LLP announces that it has filed a class action lawsuit in the United States District Court for the District of New Jersey on behalf of all persons who purchased or otherwise acquired common stock of Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company"
(NYSE:VRX) (TSX:VRX) during the period February 22, 2015 through October 21, 2015, inclusive (the "Class Period". A copy of the Complaint filed in this action can be viewed on the Wolf Haldenstein Adler Freeman & Herz LLP website at www.whafh.com.
VRX: 93.77 (-17.73), VRX.TO: 122.04 (-26.19)
Valeant cutting ties with Philidor
By DAMIAN J. TROISE - AP - Fri Oct 30, 4:23PM CDT
NEW YORK (AP) — Valeant Pharmaceuticals, a company that has come under intense scrutiny for its drug prices, has cut ties with Philidor following accusations that it was a "phantom pharmacy" used solely to artificially boost sales.
VRX: 93.77 (-17.73), UNH: 117.78 (-1.93), CVS: 98.78 (-5.02), VRX.TO: 122.04 (-26.19)
Valeant and CVS are big market movers
AP - Fri Oct 30, 4:16PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
BUD: 119.33 (+1.59), VRX: 93.77 (-17.73), LNKD: 240.87 (+23.87), FNFG: 10.35 (-0.03), EXPE: 136.30 (+9.24), CVS: 98.78 (-5.02), VRX.TO: 122.04 (-26.19)
EQUITY ALERT: Rosen Law Firm Reminds Valeant Pharmaceuticals International, Inc. Investors of Important Deadline in the Expanded Class Action Filed by the Firm
Business Wire - Fri Oct 30, 3:09PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) securities from February 28, 2014 through October 21, 2015, both dates inclusive (the "Class Period" of the important December 21, 2015 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Valeant investors under the federal securities laws. Other suits that have commenced allege a much narrower class period starting in 2015.
VRX: 93.77 (-17.73), VRX.TO: 122.04 (-26.19)
Why Valeant Pharmaceuticals Intl Inc Tumbled Again Today
Brian Orelli, The Motley Fool - Motley Fool - Fri Oct 30, 2:05PM CDT
What: Valeant Pharmaceuticals fell more than 12% today after Bloomberg reported yesterday that employees at a specialty pharmacy Philidor RX Services were changing prescriptions so that Valeant's dermatology creams and gels would be dispensed...
VRX: 93.77 (-17.73)
CVS Removes Valeant Partner Philidor from Pharmacy Network
Zacks Equity Research - Zacks Investment Research - Fri Oct 30, 2:00PM CDT
CVS Health Corporation (CVS) has gained 1.6% in aftermarket trading yesterday, following the announcement of its decision to terminate its contract with Philidor Rx Services.
VRX: 93.77 (-17.73), ESRX: 86.38 (-0.77), UNH: 117.78 (-1.93), CVS: 98.78 (-5.02)
Stocks Fall Back Into Red as Financials Lag
at The Street - Fri Oct 30, 1:55PM CDT
Stocks fall back into the red Friday afternoon as a lag in financial stocks overshadows a push higher by the energy sector.
BUD: 119.33 (+1.59), VRX: 93.77 (-17.73), C: 53.17 (-0.49), FNFG: 10.35 (-0.03), XOM: 82.74 (+0.51), BAC: 16.78 (-0.31), WFC: 54.14 (-0.95), KEY: 12.42 (-0.96), SBUX: 62.57 (+0.07), FSLR: 57.07 (+6.08), RDS.A: 52.46 (-0.10), JPM: 64.25 (-0.96), LNKD: 240.87 (+23.87), SCTY: 29.65 (-8.42), CVS: 98.78 (-5.02), BP: 35.70 (-0.01), ABBV: 59.55 (+5.45), XLF: 24.08 (-0.35), CVX: 90.88 (+0.99), PTR: 78.63 (+1.17), XLE: 68.03 (+0.44), STO: 16.16 (+0.19), CL: 66.35 (-2.88)
Dow 30 Stock Roundup: Apple, Pfizer Results Impress, Microsoft, Merck Beat on Earnings
Swarup Gupta - Zacks Investment Research - Fri Oct 30, 12:58PM CDT
A combination of factors ensured that the Dow had to suffer a relatively disappointing week.
KO: 42.35 (-0.44), MMM: 157.21 (-0.40), VRX: 93.77 (-17.73), PFE: 33.82 (-0.95), BA: 148.07 (+0.89), CCE: 51.34 (+0.22), AGN: 308.47 (+4.09), IBM: 140.08 (-0.47), MRK: 54.66 (-0.21), DD: 63.40 (+0.06), GOOGL: 737.39 (-7.46), PG: 76.38 (-0.64), MSFT: 52.64 (-0.72), AAPL: 119.50 (-1.03)
Valeant Pharmaceuticals' "Chewbacca Defense" Is Dead in the Water
Alex DUMORTIER, CFA, The Motley Fool - Motley Fool - Fri Oct 30, 12:16PM CDT
U.S. stocks are roughly unchanged early on Friday afternoon, with the Dow Jones Industrial Average and the S&P 500 up 0.20% and 0.15%, respectively, at 1 p.m. EDT. Shares of embattled pharma Valeant Pharmaceuticals International Inc , on...
VRX: 93.77 (-17.73), ESRX: 86.38 (-0.77)
3 Stocks Trading on Monster Volume -- and What to Do With Them Now
at The Street - Fri Oct 30, 11:31AM CDT
Here's a technical look at how to trade some of the most active stocks on the market today.
SBUX: 62.57 (+0.07), VRX: 93.77 (-17.73), SCTY: 29.65 (-8.42)
Valeant Dumps Philidor As Stock Keeps Hemorrhaging
at Investor's Business Daily - Fri Oct 30, 10:10AM CDT
Beleaguered drug giant Valeant Pharmaceuticals International (VRX) announced Friday that it's severing all ties with specialty pharmacy Philidor, which it said would be shutting down completely as criticism mounts over its business practices....
ESRX: 86.38 (-0.77), VRX: 93.77 (-17.73), CVS: 98.78 (-5.02)
Stocks Are Mixed as Chicago Business Activity Improves
at The Street - Fri Oct 30, 9:35AM CDT
Stocks turn mixed by mid-morning after business activity in Chicago rebounds and consumer sentiment improves.
BUD: 119.33 (+1.59), VRX: 93.77 (-17.73), WU: 19.25 (+0.24), XOM: 82.74 (+0.51), SBUX: 62.57 (+0.07), ESRX: 86.38 (-0.77), FSLR: 57.07 (+6.08), LNKD: 240.87 (+23.87), SCTY: 29.65 (-8.42), CVS: 98.78 (-5.02), ABBV: 59.55 (+5.45), CVX: 90.88 (+0.99), CL: 66.35 (-2.88)
Here's Why Valeant Pharmaceuticals (VRX) Stock Is Plunging Today
at The Street - Fri Oct 30, 8:54AM CDT
Valeant Pharmaceuticals (VRX) stock is further declining on Friday, after announcing it will cut ties with specialty pharmacy Philidor, which will shut down operations immediately.
VRX: 93.77 (-17.73)
Herbalife Trolls Bill Ackman in the Best Way Minutes Ahead of Valeant Call
at The Street - Fri Oct 30, 8:32AM CDT
Herbalife has one thing to say to Bill Ackman: "Baaaaahahahahahaha."
HLF: 56.04 (+2.41), VRX: 93.77 (-17.73)
Stock Futures Rise in Final Day of Best Month in 4 Years
at The Street - Fri Oct 30, 7:41AM CDT
Stock futures rise on Friday, on track to close out with the best monthly gain in four years.
BUD: 119.33 (+1.59), VRX: 93.77 (-17.73), WU: 19.25 (+0.24), XOM: 82.74 (+0.51), SBUX: 62.57 (+0.07), ESRX: 86.38 (-0.77), LNKD: 240.87 (+23.87), SCTY: 29.65 (-8.42), NUS: 38.21 (+3.35), CVS: 98.78 (-5.02), ABBV: 59.55 (+5.45), CL: 66.35 (-2.88)
Former Deputy Attorney General Appointed To Advise Valeant's Ad Hoc Committee
CNW Group - Fri Oct 30, 7:00AM CDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that the ad hoc committee appointed by Valeant's board of directors has appointed former Deputy Attorney General of the United States Mark Filip of Kirkland & Ellis LLP to advise the committee in its review of allegations related to Valeant's business relationship with Philidor and related matters.
VRX: 93.77 (-17.73), VRX.TO: 122.04 (-26.19)
3 Popular Stocks That Have Us Spooked
Brian Feroldi, Sean Williams, and Jason Hall, The Motley Fool - Motley Fool - Sat Oct 31, 12:17PM CDT
Photo by Brian Feroldi We Fools strongly believe that buying and holding high-quality stocks is one of the best ways to build wealth over time. Great companies can provide their investors with market-smashing returns, and turn small amounts of...
BOFI: 80.01 (-13.04), VRX: 93.77 (-17.73), MNKD: 3.31 (-0.15)
'Fast Money' Recap: October Was Great but What About November?
at The Street - Sat Oct 31, 4:00AM CDT
The trading panel discussed whether the market can rally and which stock to buy ahead of earnings.
TSLA: 206.93 (-4.70), VRX: 93.77 (-17.73), SPY: 207.93 (-0.90), SHAK: 45.57 (+1.25), DIS: 113.74 (-1.30), TM: 122.62 (-0.62), KORS: 38.64 (-0.05), KATE: 17.97 (-0.22), WEN: 9.16 (+0.09), CBS: 46.52 (-0.10)
Roll-Ups and Yahoo! Look Risky; Trust Sam Zell; A Bit of Bafflement: Best of Kass
at The Street - Fri Oct 30, 8:00PM CDT
In highlights from this week's trading diary and posts, Kass talks about roll-up problems, why he sold Yahoo!, what one proven prognosticator is selling, and why he's just plain confused.
AMZN: 625.90 (-0.65), YHOO: 35.62 (+0.57), VRX: 93.77 (-17.73), IBM: 140.08 (-0.47), SUNE: 7.30 (-1.03), GOOGL: 737.39 (-7.46), MSFT: 52.64 (-0.72), BABA: 83.83 (+1.61)
Wolf Haldenstein Adler Freeman & Herz LLP Commences a Class Action Lawsuit Against Valeant Pharmaceuticals International, Inc. in the United States District Court for the District of New Jersey -- VRX
GlobeNewswire - Fri Oct 30, 4:30PM CDT
Wolf Haldenstein Adler Freeman & Herz LLP announces that it has filed a class action lawsuit in the United States District Court for the District of New Jersey on behalf of all persons who purchased or otherwise acquired common stock of Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company"
(NYSE:VRX) (TSX:VRX) during the period February 22, 2015 through October 21, 2015, inclusive (the "Class Period". A copy of the Complaint filed in this action can be viewed on the Wolf Haldenstein Adler Freeman & Herz LLP website at www.whafh.com. VRX: 93.77 (-17.73), VRX.TO: 122.04 (-26.19)
Valeant cutting ties with Philidor
By DAMIAN J. TROISE - AP - Fri Oct 30, 4:23PM CDT
NEW YORK (AP) — Valeant Pharmaceuticals, a company that has come under intense scrutiny for its drug prices, has cut ties with Philidor following accusations that it was a "phantom pharmacy" used solely to artificially boost sales.
VRX: 93.77 (-17.73), UNH: 117.78 (-1.93), CVS: 98.78 (-5.02), VRX.TO: 122.04 (-26.19)
Valeant and CVS are big market movers
AP - Fri Oct 30, 4:16PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
BUD: 119.33 (+1.59), VRX: 93.77 (-17.73), LNKD: 240.87 (+23.87), FNFG: 10.35 (-0.03), EXPE: 136.30 (+9.24), CVS: 98.78 (-5.02), VRX.TO: 122.04 (-26.19)
EQUITY ALERT: Rosen Law Firm Reminds Valeant Pharmaceuticals International, Inc. Investors of Important Deadline in the Expanded Class Action Filed by the Firm
Business Wire - Fri Oct 30, 3:09PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) securities from February 28, 2014 through October 21, 2015, both dates inclusive (the "Class Period"
of the important December 21, 2015 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Valeant investors under the federal securities laws. Other suits that have commenced allege a much narrower class period starting in 2015. VRX: 93.77 (-17.73), VRX.TO: 122.04 (-26.19)
Why Valeant Pharmaceuticals Intl Inc Tumbled Again Today
Brian Orelli, The Motley Fool - Motley Fool - Fri Oct 30, 2:05PM CDT
What: Valeant Pharmaceuticals fell more than 12% today after Bloomberg reported yesterday that employees at a specialty pharmacy Philidor RX Services were changing prescriptions so that Valeant's dermatology creams and gels would be dispensed...
VRX: 93.77 (-17.73)
CVS Removes Valeant Partner Philidor from Pharmacy Network
Zacks Equity Research - Zacks Investment Research - Fri Oct 30, 2:00PM CDT
CVS Health Corporation (CVS) has gained 1.6% in aftermarket trading yesterday, following the announcement of its decision to terminate its contract with Philidor Rx Services.
VRX: 93.77 (-17.73), ESRX: 86.38 (-0.77), UNH: 117.78 (-1.93), CVS: 98.78 (-5.02)
Stocks Fall Back Into Red as Financials Lag
at The Street - Fri Oct 30, 1:55PM CDT
Stocks fall back into the red Friday afternoon as a lag in financial stocks overshadows a push higher by the energy sector.
BUD: 119.33 (+1.59), VRX: 93.77 (-17.73), C: 53.17 (-0.49), FNFG: 10.35 (-0.03), XOM: 82.74 (+0.51), BAC: 16.78 (-0.31), WFC: 54.14 (-0.95), KEY: 12.42 (-0.96), SBUX: 62.57 (+0.07), FSLR: 57.07 (+6.08), RDS.A: 52.46 (-0.10), JPM: 64.25 (-0.96), LNKD: 240.87 (+23.87), SCTY: 29.65 (-8.42), CVS: 98.78 (-5.02), BP: 35.70 (-0.01), ABBV: 59.55 (+5.45), XLF: 24.08 (-0.35), CVX: 90.88 (+0.99), PTR: 78.63 (+1.17), XLE: 68.03 (+0.44), STO: 16.16 (+0.19), CL: 66.35 (-2.88)
Dow 30 Stock Roundup: Apple, Pfizer Results Impress, Microsoft, Merck Beat on Earnings
Swarup Gupta - Zacks Investment Research - Fri Oct 30, 12:58PM CDT
A combination of factors ensured that the Dow had to suffer a relatively disappointing week.
KO: 42.35 (-0.44), MMM: 157.21 (-0.40), VRX: 93.77 (-17.73), PFE: 33.82 (-0.95), BA: 148.07 (+0.89), CCE: 51.34 (+0.22), AGN: 308.47 (+4.09), IBM: 140.08 (-0.47), MRK: 54.66 (-0.21), DD: 63.40 (+0.06), GOOGL: 737.39 (-7.46), PG: 76.38 (-0.64), MSFT: 52.64 (-0.72), AAPL: 119.50 (-1.03)
Valeant Pharmaceuticals' "Chewbacca Defense" Is Dead in the Water
Alex DUMORTIER, CFA, The Motley Fool - Motley Fool - Fri Oct 30, 12:16PM CDT
U.S. stocks are roughly unchanged early on Friday afternoon, with the Dow Jones Industrial Average and the S&P 500 up 0.20% and 0.15%, respectively, at 1 p.m. EDT. Shares of embattled pharma Valeant Pharmaceuticals International Inc , on...
VRX: 93.77 (-17.73), ESRX: 86.38 (-0.77)
3 Stocks Trading on Monster Volume -- and What to Do With Them Now
at The Street - Fri Oct 30, 11:31AM CDT
Here's a technical look at how to trade some of the most active stocks on the market today.
SBUX: 62.57 (+0.07), VRX: 93.77 (-17.73), SCTY: 29.65 (-8.42)
Valeant Dumps Philidor As Stock Keeps Hemorrhaging
at Investor's Business Daily - Fri Oct 30, 10:10AM CDT
Beleaguered drug giant Valeant Pharmaceuticals International (VRX) announced Friday that it's severing all ties with specialty pharmacy Philidor, which it said would be shutting down completely as criticism mounts over its business practices....
ESRX: 86.38 (-0.77), VRX: 93.77 (-17.73), CVS: 98.78 (-5.02)
Stocks Are Mixed as Chicago Business Activity Improves
at The Street - Fri Oct 30, 9:35AM CDT
Stocks turn mixed by mid-morning after business activity in Chicago rebounds and consumer sentiment improves.
BUD: 119.33 (+1.59), VRX: 93.77 (-17.73), WU: 19.25 (+0.24), XOM: 82.74 (+0.51), SBUX: 62.57 (+0.07), ESRX: 86.38 (-0.77), FSLR: 57.07 (+6.08), LNKD: 240.87 (+23.87), SCTY: 29.65 (-8.42), CVS: 98.78 (-5.02), ABBV: 59.55 (+5.45), CVX: 90.88 (+0.99), CL: 66.35 (-2.88)
Here's Why Valeant Pharmaceuticals (VRX) Stock Is Plunging Today
at The Street - Fri Oct 30, 8:54AM CDT
Valeant Pharmaceuticals (VRX) stock is further declining on Friday, after announcing it will cut ties with specialty pharmacy Philidor, which will shut down operations immediately.
VRX: 93.77 (-17.73)
Herbalife Trolls Bill Ackman in the Best Way Minutes Ahead of Valeant Call
at The Street - Fri Oct 30, 8:32AM CDT
Herbalife has one thing to say to Bill Ackman: "Baaaaahahahahahaha."
HLF: 56.04 (+2.41), VRX: 93.77 (-17.73)
Stock Futures Rise in Final Day of Best Month in 4 Years
at The Street - Fri Oct 30, 7:41AM CDT
Stock futures rise on Friday, on track to close out with the best monthly gain in four years.
BUD: 119.33 (+1.59), VRX: 93.77 (-17.73), WU: 19.25 (+0.24), XOM: 82.74 (+0.51), SBUX: 62.57 (+0.07), ESRX: 86.38 (-0.77), LNKD: 240.87 (+23.87), SCTY: 29.65 (-8.42), NUS: 38.21 (+3.35), CVS: 98.78 (-5.02), ABBV: 59.55 (+5.45), CL: 66.35 (-2.88)
Former Deputy Attorney General Appointed To Advise Valeant's Ad Hoc Committee
CNW Group - Fri Oct 30, 7:00AM CDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that the ad hoc committee appointed by Valeant's board of directors has appointed former Deputy Attorney General of the United States Mark Filip of Kirkland & Ellis LLP to advise the committee in its review of allegations related to Valeant's business relationship with Philidor and related matters.
VRX: 93.77 (-17.73), VRX.TO: 122.04 (-26.19)
